CN104825696A - Traditional Chinese medicine preparation for reducing blood fat - Google Patents
Traditional Chinese medicine preparation for reducing blood fat Download PDFInfo
- Publication number
- CN104825696A CN104825696A CN201510273067.7A CN201510273067A CN104825696A CN 104825696 A CN104825696 A CN 104825696A CN 201510273067 A CN201510273067 A CN 201510273067A CN 104825696 A CN104825696 A CN 104825696A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- blood fat
- medicine preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine preparation for reducing blood fat. The traditional Chinese medicine preparation comprises, by weight, 3-6 parts of eclipta, 5-8 parts of salvia miltiorrhiza, 7-9 parts of lingzhi mushroom, 5-8 parts of pseudo-ginseng, 8-10 parts of astragalus membranaceus, 4-6 parts of fructus lycii, 2-4 parts of rhizoma alismatis, 5-7 parts of radix paeoniae alba, 3-5 parts of hawthorn, 6-8 parts of radix polygoni multiflori preparata, 3-5 parts of Chinese taxillus twig, 6-8 parts of longhairy antenoron herb, 4-6 parts of dried rehmannia root, 7-9 parts of root of kudzu vine and 5-7 parts of akebia stem. The traditional Chinese medicine preparation is low in cost, prepared from pure Chinese herbs, free of toxic and side effects on human bodies and remarkable in curative effect and is an excellent blood fat reducing drug.
Description
Technical field
The present invention relates to the treatment field of Chinese medicines, is exactly a kind of Chinese medicine of blood fat reducing.
Background technology
At present, the patient of hyperlipidemia is very general, and it comprises hypercholesterolemia, hypertriglyceridemia and plyability hyperlipemia, and this is one of principal element causing atherosclerosis and coronary heart disease.It also produces the impact that can not be ignored on kidney, peripheral circulation, pancreas, pruritus, immune system, disease in the blood system.
Blood fat is a kind of important material in human body, has many very important functions, but can not exceed certain scope.If hyperlipoidemia, easily cause " blood is thick ", blood vessel wall deposits, form little speckle gradually, these " specklees " increase, increase, artery-clogging gradually, and make blood flow slack-off, time serious, blood flow is interrupted.If this situation occurs in heart, just cause coronary heart disease; Occur in brain, just there will be apoplexy; If blocking optical fundus blood vessel, visual deterioration, blind will be caused; If occur in kidney, renal arteriosclerosis will be caused, renal failure.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine of blood fat reducing evident in efficacy.
The present invention adopts following technical scheme:
A kind of Chinese medicine of blood fat reducing, it is characterized in that, it is made up of the raw material of Chinese medicine of following weight proportion: Herba Ecliptae 3-6, Radix Salviae Miltiorrhizae 5-8, Ganoderma 7-9, Radix Notoginseng 5-8, Radix Astragali 8-10, fructus lycii 4-6, Rhizoma Alismatis 2-4, Radix Paeoniae Alba 5-7, Fructus Crataegi 3-5, Radix Polygoni Multiflori Preparata 6-8, Herba Taxilli 3-5, Herba Lysimachiae 6-8, Radix Rehmanniae 4-6, Radix Puerariae 7-9, Caulis Akebiae 5-7.
The Chinese medicine of described blood fat reducing, is characterized in that: it is made up of the crude drug of following weight portion: Herba Ecliptae 6, Radix Salviae Miltiorrhizae 8, Ganoderma 8, Radix Notoginseng 7, the Radix Astragali 9, fructus lycii 6, Rhizoma Alismatis 2-4, the Radix Paeoniae Alba 7, Fructus Crataegi 5, Radix Polygoni Multiflori Preparata 7, Herba Taxilli 5, Herba Lysimachiae 8, Radix Rehmanniae 6, Radix Puerariae 8, Caulis Akebiae 7.
Advantage of the present invention is as follows:
The present invention accepts clinic case more than 98 people for medical treatment, and total effective rate reaches 88%, and it is low that the present invention has cost, and pure Chinese herbal medicine is made, and has no side effect to health, evident in efficacy, is a kind of excellent hypolipidemic.Wherein Rhizoma Alismatis has promoting diuresis to eliminate damp pathogen, expels the heat-evil, and changes effect of turbid blood fat reducing.
Detailed description of the invention
The Chinese medicine of described blood fat reducing, it is made up of the crude drug of following weight portion (g): Herba Ecliptae 6, Radix Salviae Miltiorrhizae 8, Ganoderma 8, Radix Notoginseng 7, the Radix Astragali 9, fructus lycii 6, Rhizoma Alismatis 2-4, the Radix Paeoniae Alba 7, Fructus Crataegi 5, Radix Polygoni Multiflori Preparata 7, Herba Taxilli 5, Herba Lysimachiae 8, Radix Rehmanniae 6, Radix Puerariae 8, Caulis Akebiae 7.
Usage and consumption: take 1 note day, decoct water, divide and take for 2 to 3 times.Within 7 days, be a course for the treatment of, generally take 1-3 the course for the treatment of.
Claims (2)
1. the Chinese medicine of a blood fat reducing, it is characterized in that, it is made up of the raw material of Chinese medicine of following weight proportion: Herba Ecliptae 3-6, Radix Salviae Miltiorrhizae 5-8, Ganoderma 7-9, Radix Notoginseng 5-8, Radix Astragali 8-10, fructus lycii 4-6, Rhizoma Alismatis 2-4, Radix Paeoniae Alba 5-7, Fructus Crataegi 3-5, Radix Polygoni Multiflori Preparata 6-8, Herba Taxilli 3-5, Herba Lysimachiae 6-8, Radix Rehmanniae 4-6, Radix Puerariae 7-9, Caulis Akebiae 5-7.
2. the Chinese medicine of blood fat reducing according to claim 1, is characterized in that: it is made up of the crude drug of following weight portion: Herba Ecliptae 6, Radix Salviae Miltiorrhizae 8, Ganoderma 8, Radix Notoginseng 7, the Radix Astragali 9, fructus lycii 6, Rhizoma Alismatis 2-4, the Radix Paeoniae Alba 7, Fructus Crataegi 5, Radix Polygoni Multiflori Preparata 7, Herba Taxilli 5, Herba Lysimachiae 8, Radix Rehmanniae 6, Radix Puerariae 8, Caulis Akebiae 7.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510273067.7A CN104825696A (en) | 2015-05-26 | 2015-05-26 | Traditional Chinese medicine preparation for reducing blood fat |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510273067.7A CN104825696A (en) | 2015-05-26 | 2015-05-26 | Traditional Chinese medicine preparation for reducing blood fat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104825696A true CN104825696A (en) | 2015-08-12 |
Family
ID=53804145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510273067.7A Pending CN104825696A (en) | 2015-05-26 | 2015-05-26 | Traditional Chinese medicine preparation for reducing blood fat |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104825696A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107496697A (en) * | 2017-08-23 | 2017-12-22 | 广西桂平市石龙镇江夏种养专业合作社 | A kind of lipid-loweringing Ramulus Taxilli medicinal herb tea |
| CN113244339A (en) * | 2021-06-04 | 2021-08-13 | 南京厚生药业有限公司 | Cholestyramine powder for hyperlipidemia and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104547881A (en) * | 2013-10-16 | 2015-04-29 | 栾晓明 | Traditional Chinese medicine for reducing blood lipids |
-
2015
- 2015-05-26 CN CN201510273067.7A patent/CN104825696A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104547881A (en) * | 2013-10-16 | 2015-04-29 | 栾晓明 | Traditional Chinese medicine for reducing blood lipids |
Non-Patent Citations (4)
| Title |
|---|
| 张晓刚主编: "《降血脂偏方秘方》", 30 November 2008, 内蒙古人民出版社 * |
| 金亚明主编: "《家用补益中药》", 31 January 2012, 江苏科学技术出版社 * |
| 雷载权主编: "《中药学》", 30 June 1995, 上海科学技术出版社 * |
| 高望宗等: "《冠心病防治宜与忌》", 31 December 2011, 兰州大学出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107496697A (en) * | 2017-08-23 | 2017-12-22 | 广西桂平市石龙镇江夏种养专业合作社 | A kind of lipid-loweringing Ramulus Taxilli medicinal herb tea |
| CN113244339A (en) * | 2021-06-04 | 2021-08-13 | 南京厚生药业有限公司 | Cholestyramine powder for hyperlipidemia and preparation method thereof |
| CN113244339B (en) * | 2021-06-04 | 2021-09-24 | 南京厚生药业有限公司 | Cholestyramine powder for hyperlipidemia and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103316222A (en) | Traditional Chinese medicine composition for treating pleurisy and preparation method thereof | |
| CN101513497A (en) | Method for preparing antifat decoction | |
| CN104825696A (en) | Traditional Chinese medicine preparation for reducing blood fat | |
| CN101181519A (en) | Hongxue Tea particle for curing hypertension and hyperlipemia | |
| CN1186687A (en) | Cancer preventing curing medicine series and its preparation | |
| CN103690839A (en) | Traditional Chinese medicine capsules for treating constipation by using aloe | |
| CN101301444A (en) | Decoction for curing kidney | |
| CN107296861A (en) | A kind of Chinese medicine of reducing blood lipid | |
| CN104606573A (en) | Traditional Chinese medicine used for treating arthritis | |
| CN103690825A (en) | Weight reduction health care traditional Chinese medicine capsules | |
| CN103275856A (en) | Health liquor | |
| CN104887867A (en) | Traditional Chinese medicine for reducing blood lipid | |
| CN103169855A (en) | Drug composition for treating chronic heart failure | |
| CN101683446A (en) | Traditional Chinese medicine composition with function of invigorating circulation and reducing blood fat | |
| CN103735879A (en) | Traditional Chinese medicine decoction for treating carotid artery plaque | |
| CN107029068A (en) | A kind of Chinese medicine of reducing blood lipid | |
| CN103721020A (en) | Blood circulation promoting and meridian unlocking granule for treating cerebral thrombosis and preparation method of granule | |
| CN103877504A (en) | Formula and preparation method of traditional Chinese herbal medicine for treating hepatitis B and preparation method thereof | |
| CN104800391A (en) | Traditional Chinese medicine for treating hepatitis | |
| CN102397403A (en) | Medicine for treating kidney dysfunction | |
| CN102861268A (en) | Traditional Chinese medicine for treating rheumatoid arthritis | |
| CN101062206A (en) | Traditional Chinese medicine prescription for tonifying kidney and spleen | |
| CN103735642A (en) | Traditional Chinese medicine for preventing influenza | |
| CN103656271A (en) | Traditional Chinese medicine composition for treating chronic cholecystitis | |
| CN104815283A (en) | Traditional Chinese medicine used for treating viral hepatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| DD01 | Delivery of document by public notice |
Addressee: Hu Le Document name: Notification of Approving Refund |
|
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150812 |